Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden

Figure 1

Number of patients starting anti-tumour necrosis factor (TNF) therapy during the observational period. The figure presents the number of rheumatoid arthritis patients, per quarter, starting infliximab, etanercept, or adalimumab for the first time during the period of 1999 through 2004 in southern Sweden.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us